Literature DB >> 16482471

Effects of nano particles on cytokine expression in murine lung in the absence or presence of allergen.

Ken-Ichiro Inoue1, Hirohisa Takano, Rie Yanagisawa, Takamichi Ichinose, Miho Sakurai, Toshikazu Yoshikawa.   

Abstract

Particulate matter (PM) can exacerbate allergic airway diseases. Health effects of PM with a diameter of less than 100 nm, called nano particles, have been focused. We have recently demonstrated that carbon nano particles (14, 56 nm) exaggerate allergic airway inflammation in mice. In the present study, we investigated the effects of repeated pulmonary exposure to carbon nano particles on the expression of a variety of cytokines in the absence or presence of allergen in mice. ICR mice were divided into six experimental groups. Vehicle, two sizes of carbon nano particles, ovalbumin (OVA), and OVA + nano particles were administered intratracheally. Nano particles increased the lung protein levels of thymus and activation-regulated chemokine (TARC), macrophage inflammatory protein (MIP)-1alpha, and granulocyte-macrophage colony-stimulating factor (GM-CSF) in the absence or presence of allergen. The enhancement was more prominent with 14 nm of nano particles than with 56 nm of nano particles in overall trend. 14 nm nano particle exposure significantly enhanced the lung expressions of interleukin (IL)-2 and IL-10 in the presence of allergen as compared with allergen exposure. These results suggest that pulmonary exposure to nano particles can induce the lung expression of TARC, MIP-1alpha, GM-CSF in the absence of allergen and can enhance that of TARC, MIP-1alpha, GM-CSF, IL-2, and IL-10 in the presence of allergen. The enhancing effects are more prominent with smaller particles.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16482471     DOI: 10.1007/s00204-006-0075-3

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  10 in total

Review 1.  Pulmonary applications and toxicity of engineered nanoparticles.

Authors:  Jeffrey W Card; Darryl C Zeldin; James C Bonner; Earle R Nestmann
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-07-18       Impact factor: 5.464

2.  IL-33 mediates multi-walled carbon nanotube (MWCNT)-induced airway hyper-reactivity via the mobilization of innate helper cells in the lung.

Authors:  Celine A Beamer; Teri A Girtsman; Benjamin P Seaver; Krissy J Finsaas; Christopher T Migliaccio; Victoria K Perry; James B Rottman; Dirk E Smith; Andrij Holian
Journal:  Nanotoxicology       Date:  2012-06-29       Impact factor: 5.913

3.  Combustion-derived nanoparticle exposure and household solid fuel use in Xuanwei and Fuyuan, China.

Authors:  H Dean Hosgood; Roel Vermeulen; Hu Wei; Boris Reiss; Joseph Coble; Fusheng Wei; Xu Jun; Guoping Wu; Nat Rothman; Qing Lan
Journal:  Int J Environ Health Res       Date:  2012-05-28       Impact factor: 3.411

Review 4.  Mechanistic insight into the impact of nanomaterials on asthma and allergic airway disease.

Authors:  Kirsty Meldrum; Chang Guo; Emma L Marczylo; Timothy W Gant; Rachel Smith; Martin O Leonard
Journal:  Part Fibre Toxicol       Date:  2017-11-21       Impact factor: 9.400

Review 5.  Green Synthesis of Selenium and Tellurium Nanoparticles: Current Trends, Biological Properties and Biomedical Applications.

Authors:  Marjorie C Zambonino; Ernesto Mateo Quizhpe; Francisco E Jaramillo; Ashiqur Rahman; Nelson Santiago Vispo; Clayton Jeffryes; Si Amar Dahoumane
Journal:  Int J Mol Sci       Date:  2021-01-20       Impact factor: 5.923

6.  The effect of titanium dioxide nanoparticles on pulmonary surfactant function and ultrastructure.

Authors:  Carsten Schleh; Christian Mühlfeld; Karin Pulskamp; Andreas Schmiedl; Matthias Nassimi; Hans D Lauenstein; Armin Braun; Norbert Krug; Veit J Erpenbeck; Jens M Hohlfeld
Journal:  Respir Res       Date:  2009-09-30

7.  Engineered silica nanoparticles act as adjuvants to enhance allergic airway disease in mice.

Authors:  Christina Brandenberger; Nicole L Rowley; Daven N Jackson-Humbles; Quanxuan Zhang; Lori A Bramble; Ryan P Lewandowski; James G Wagner; Weimin Chen; Barbara L Kaplan; Norbert E Kaminski; Gregory L Baker; Robert M Worden; Jack R Harkema
Journal:  Part Fibre Toxicol       Date:  2013-07-01       Impact factor: 9.400

8.  Effects of ultrafine particles on the allergic inflammation in the lung of asthmatics: results of a double-blinded randomized cross-over clinical pilot study.

Authors:  Frank Schaumann; Cornelia Frömke; Dorothea Dijkstra; Francesca Alessandrini; Horst Windt; Erwin Karg; Meike Müller; Carla Winkler; Armin Braun; Armin Koch; Jens Michael Hohlfeld; Heidrun Behrendt; Otmar Schmid; Wolfgang Koch; Holger Schulz; Norbert Krug
Journal:  Part Fibre Toxicol       Date:  2014-09-10       Impact factor: 9.400

9.  Influence of Seasonality and Circulating Cytokines on Serial QuantiFERON Discordances.

Authors:  Marsha L Griffin; Saroochi Agarwal; Melissa Zhu Murphy; Larry D Teeter; Edward A Graviss
Journal:  Tuberc Res Treat       Date:  2018-03-12

10.  Novel Nanoparticulate and Ionic Titanium Antigens for Hypersensitivity Testing.

Authors:  Paul Johan Høl; Einar K Kristoffersen; Nils Roar Gjerdet; Amanda S Pellowe
Journal:  Int J Mol Sci       Date:  2018-04-06       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.